Search

Adaptive Biotechnologies Corp

Затворен

28.29 3.47

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

28.1

Максимум

28.37

Ключови измерители

By Trading Economics

Приходи

-20M

-40M

Продажби

679K

72M

EPS

-0.1

Марж на печалбата

-55.82

Служители

624

EBITDA

2.3M

-12M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+3.55% upside

Дивиденти

By Acuity

Следващи печалби

4.11.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

943M

4.6B

Предишно отваряне

24.82

Предишно затваряне

28.29

Adaptive Biotechnologies Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.10.2026 г., 23:31 ч. UTC

Brazil's September Inflation Rate Release on October 9 Expected to Show Significant Change Amid Global Price Pressures.

3.10.2026 г., 23:31 ч. UTC

Brazil's September inflation rate report on October 9, 2026, could influence market sentiment and investment strategies amid rising price concerns ahead of presidential elections.

3.10.2026 г., 23:11 ч. UTC

Mexico's Inflation Rate MoM Release on October 8, 2026 Expected to Impact Market Sentiment Amid Global Economic Pressures.

3.10.2026 г., 23:11 ч. UTC

Mexico's Inflation Rate Expected to Rise in September 2026 Amid Global Price Pressures, Analysts Warn of Economic Implications

3.10.2026 г., 22:51 ч. UTC

Macro News

The Nasdaq 100 Index (US) declined in after-market trading, influenced by concerns over $3.8 trillion in off-balance sheet debt among major hyperscalers.

3.10.2026 г., 22:51 ч. UTC

Macro News

The Dow Jones Index traded lower in after-market hours amid concerns over $3.8 trillion in off-balance sheet liabilities in the hyperscaler industry.

3.10.2026 г., 22:51 ч. UTC

Japan's Household Spending Data Release on October 8 Expected to Reflect Consumer Trends Amid Rising Inflation and Market Caution.

3.10.2026 г., 22:51 ч. UTC

Japan's Household Spending YoY Expected to Decline Further Amid Rising Inflation and Economic Uncertainty

3.10.2026 г., 22:51 ч. UTC

Japan's Current Account Release on October 7 Expected to Reflect Economic Health Amid Mixed Consumer Price Sentiment and Global Demand Concerns.

3.10.2026 г., 22:50 ч. UTC

Macro News

The FTSE 100 Index traded modestly higher during after-market hours, amid rising U.S. Treasury yields and volatile Brent crude oil prices.

3.10.2026 г., 22:11 ч. UTC

UK Housing Market Outlook Remains Cautiously Pessimistic Ahead of RICS House Price Balance Report, Forecasting -0.3% Decline

3.10.2026 г., 22:11 ч. UTC

U.S. 30-Year Mortgage Rates Expected to Rise Amid Inflation Concerns and Weak Job Growth, Impacting Housing Affordability

3.10.2026 г., 21:51 ч. UTC

Australia's Westpac Consumer Confidence Index set for October 5 release amid positive investor sentiment and market recovery, despite global economic uncertainties.

3.10.2026 г., 21:51 ч. UTC

Australia's Consumer Confidence Report on October 5, 2026, amid cautious optimism following a sharp September decline and ongoing inflationary pressures.

3.10.2026 г., 21:50 ч. UTC

Palladium is trading higher since Friday's close, despite remaining significantly below its 20-day moving average amid ongoing volatility in energy prices.

3.10.2026 г., 21:31 ч. UTC

Spain's Consumer Confidence Index Set for Release Amid Mixed Market Sentiment and Geopolitical Tensions on October 9, 2026.

3.10.2026 г., 20:41 ч. UTC

Australia's Ai Group Industry Index set for release on October 6, with expectations of recovery from August's -3.5 amid cautious optimism in the stock market and potential positive impacts on related sectors.

3.10.2026 г., 20:21 ч. UTC

Turkey's Trade Balance Data Release on October 5, 2026: Market Anticipates Widening Deficit Amid Global Economic Pressures.

3.10.2026 г., 20:21 ч. UTC

API Crude Oil Stock Change Report Due October 6, Amid Market Volatility and Geopolitical Tensions Impacting Energy Prices.

3.10.2026 г., 19:31 ч. UTC

Euro Area Retail Sales Expected to Rise 0.4% Amid Mixed Consumer Trends and Rising Inflation

3.10.2026 г., 19:31 ч. UTC

Italy's Industrial Production MoM data for August 2026 set to release on October 9, with market expectations at a flat growth of 0.0% amid mixed economic signals and recent retail sales increase.

3.10.2026 г., 18:41 ч. UTC

The Nikkei 225 Index is advancing in after-market hours, continuing its rise from Friday's close amid concerns over market concentration and volatility.

3.10.2026 г., 18:40 ч. UTC

GBP/CAD is roughly flat as the market remains closed for the weekend, reflecting stability near the upper end of its one-month trading range.

3.10.2026 г., 18:40 ч. UTC

Macro News

Oil prices are modestly higher since Friday's close, driven by U.S. sanctions impacting Iran's oil revenue streams during the weekend market closure.

3.10.2026 г., 18:31 ч. UTC

Switzerland's Consumer Confidence Index for September 2026 forecasted at -31.0, reflecting ongoing negative sentiment amid mixed global economic signals and upcoming central bank decisions.

3.10.2026 г., 18:31 ч. UTC

Turkey's Industrial Production YoY data release on October 9, 2026, signals ongoing economic contraction concerns amid declining output trends.

3.10.2026 г., 18:01 ч. UTC

Italy's S&P Global Services PMI set for October 5, with expectations of moderate growth at 53.0 amid cautious market sentiment influenced by global economic concerns.

3.10.2026 г., 17:41 ч. UTC

France's Balance of Trade report on October 7, 2026, anticipates a €6.5 billion deficit amid rising inflation and import dependency concerns.

3.10.2026 г., 17:41 ч. UTC

Switzerland's Unemployment Rate Release on October 6 Expected to Reflect Labor Market Stability Amid Global Economic Volatility.

3.10.2026 г., 17:31 ч. UTC

Spain's S&P Global Services PMI for September 2026 set to release on October 5, with analysts predicting a slight decline from August’s strong reading amid cautious market sentiment.

Сравнение с други в отрасъла

Ценова промяна

Adaptive Biotechnologies Corp Прогноза

Ценова цел

By TipRanks

3.55% нагоре

12-месечна прогноза

Среден 29.357 USD  3.55%

Висок 35 USD

Нисък 22 USD

Според 9 анализатори от Wall Street, предложили 12-месечна ценова цел за Adaptive Biotechnologies Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

9 ratings

8

Купи

1

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.